Human infection with Eurasian avian-like influenza A(H1N1) virus, China.
Da-Yan
DY
Wang
Shun-Xiang
SX
Qi
Xi-Yan
XY
Li
Jun-Feng
JF
Guo
Min-Ju
MJ
Tan
Guang-Yue
GY
Han
Yan-Fang
YF
Liu
Yu
Y
Lan
Lei
L
Yang
Wei-Juan
WJ
Huang
Yan-Hui
YH
Cheng
Xiang
X
Zhao
Tian
T
Bai
Zhao
Z
Wang
He-Jiang
HJ
Wei
Ning
N
Xiao
Yue-Long
YL
Shu
D000293:Adolescent; D000328:Adult; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D002675:Child, Preschool; D002681:China; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics* / Q000302:isolation & purification; D007252:Influenza Vaccines / Q000276:immunology; D007251:Influenza, Human / Q000175:diagnosis* / Q000188:drug therapy / Q000821:virology; D008297:Male; D008875:Middle Aged; D025202:Molecular Diagnostic Techniques; D058885:Multilocus Sequence Typing; D053139:Oseltamivir / Q000627:therapeutic use; D012756:Sheep; D014611:Vaccination; D064166:Vaccine Potency; D055815:Young Adult
D000998:Antiviral Agents; D007106:Immune Sera; D007252:Influenza Vaccines; D053139:Oseltamivir
avian-like influenza A(H1N1); influenza; serology; surveillance; viruses